Inhibitory activities of prenylated flavonoids from Sophora flavescens against aldose reductase and generation of advanced glycation endproducts

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 9, 2008, Pages 1227-1236

  Jung, Hyun Ah ^a   Yoon, Na Young ^a   Kang, Sam Sik ^b   Kim, Yeong Sik ^b   Choi, Jae Sue ^a  

^a Pukyong National University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2' METHOXYKURARINONE; 3BETA,7,4' TRIHYDROXY 5 METHOXY 8 (GAMMA.GAMMA DIMETHYLALLY)FLAVONE; 7,4' DIHYDROXY 5 METHOXY 8 (GAMMA.GAMMA DIMETHYLALLY)FLAVONE; 8 LAVANDULYLKAEMPFEROL; ADVANCED GLYCATION END PRODUCT; ALDEHYDE REDUCTASE; AMINOGUANIDINE; CHALCONE DERIVATIVE; DESMETHYLANHYDROICARITIN; EPALRESTAT; FLAVONE DERIVATIVE; FLAVONOL DERIVATIVE; KURARIDIN; KURARIDINOL; KURARINOL; KURARINONE; KUSHENOL C; KUSHENOL E; LEACHIANONE G; QUERCETIN; SOPHORA FLAVESCENS EXTRACT; SOPHORAFLAVONE G; XANTHOHUMOL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; NONHUMAN; RAT; SOPHORA; SOPHORA FLAVESCENS;

ALDEHYDE REDUCTASE; ANIMALS; CHALCONES; FLAVONES; FLAVONOIDS; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; HUMANS; INHIBITORY CONCENTRATION 50; MEDICINE, TRADITIONAL; PLANT EXTRACTS; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY; RHODANINE; SOPHORA; THIAZOLIDINES;

EID: 49749122118     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.9.0016     Document Type: Article

References (49)

1. AACE (American Association of Clinical Endocrinologists). State of Diabetes in America: A comprehensive report issued by the American Association of Clinical Endocrinologists. In: Summary Report on National Business Coalition on Health Activities Related to Diabetes, May 2007, Summary of Activities Related to Diabetes, NBCH, 2007
2. Ahmed, N., Thornalley. P. J. (2007) Advanced glycation endproducts: what is their relevance to diabetic complications? Diabetes Obes. Metab. 9: 233-245
3. Brownlee, M. (2001) Biochemistry and molecular cell biology of diabetic complications, Nature 414: 813-820
4. Chen, L., Cheng, X., Shi, W., Lu, Q., Go, V. L., Heber, D., Ma, L. (2005) Inhibition of growth of Streptococcus mutans, methicillin-resistant Staphylococcus aureus, and vancomycin-resistant enterococci by kurarinone, a bioactive flavonoid isolated from Sophora flavescens. J. Clin. Microbiol. 43: 3574-3575
5. Chi, Y. S., Jong, H. C., Son, K. H., Chang, H. W., Kang, S. S., Kim, H. P. (2001) Effects of naturally occurring prenylated flavonoids on enzymes metabolizing arachidonic acid: cyclooxygenases and lipoxygenases. Biochem. Pharmacol. 62: 1185-1191
6. de la Fuente, J. A., Manzanaro, S., Martín, M. J., de Quesada, T. G., Reymundo, I., Luengo, S. M., Gago, F. (2003) Synthesis, activity, and molecular modeling studies of novel human aldose reductase inhibitors based on a marine natural product. J. Med. Chem. 46: 5208-5221
7. De Naeyer, A., Vanden Berghe, W., Pocock, V., Milligan, S., Haegeman, G.., De Keukeleire, D. (2004) Estrogenic and anticarcinogenic properties of kurarinone, a lavandulyl flavanone from the roots of Sophora flavescens. J. Nat. Prod. 67: 1829-1832
8. Ding, P. L., Liao, Z. X., Huang, H., Zhou, P., Chen, D. F. (2006) (+)-12α-Hydroxysophocarpine, a new quinolizidine alkaloid and related anti-HBV alkaloids from Sophora flavesencs. Bioorg. Med. Chem. Lett. 16: 1231-1235
9. El-Kabbani, O., Podjarny, A. (2007) Selectivity determinants of the aldose and aldehyde reductase inhibitor-binding sites. Cell Mol. Life Sci. 64: 1970-1978
10. Hayman, S., Kinoshita, J. H. (1965) Isolation and properties of lens aldose reductase. J. Biol. Chem. 240: 877-882
11. Huang, K. C. (1993) The pharmacology of Chinese herbs. CRC press Inc., Boca Raton: FL, pp 63-66
12. Hwang. J. S., Lee, S. A., Hong, S. S., Lee, K. S., Lee, M. K., Hwang, B. Y., Ro, J. S. (2005) Monoamine oxidase inhibitory components from the roots of Sophora flavescens. Arch. Pharm. Res. 28: 190-194
13. Iwata, S., Nagata, N., Omae, A., Yamaguchi, S., Okada. Y., Shibata, S., Okuyama, T. (1999) Inhibitory effect of chalcone derivatives on recombinant human aldose reductase. Biol. Pharm. Bull. 22: 323-325
14. Jiang, H., Hou, C., Zhang, S., Xie, H., Zhou, W., Jin, Q., Cheng, X., Qian, R., Zhang, X. (2007) Matrine upregulates the cell cycle protein E2F-1 and triggers apoptosis via the mitochondrial pathway in K562 cells. Eur. J. Pharmacol. 559: 98-108
15. Jung, M. J., Kang, S. S., Jung, H. A., Kim, G. J., Choi, J. S. (2004) Isolation of flavonoids and a cerebroside from the stem bark of Albizzia julibrissin. Arch. Pharm. Res. 27: 593-599
16. - scavengers from Sophora flavescens. Arch. Pharm. Res. 28: 534-540
17. - scavenging activities from Sophora flavescens. Arch. Pharm. Res. 28: 1333-1336
18. Jung, C. H., Zhou, S., Ding, G. X., Kim, J. H., Hong, M. H., Shin, Y. C., Kim, G. J., Ko, S. G. (2006) Antihyperglycemic activity of herb extracts on streptozotocin-induced diabetic rats. Biosci. Biotechnol. Biochem. 70: 2556-2559
19. Jung, H. A., Jeong, D. M., Chung, H. Y., Lim, H. A., Kim, J. Y., Yoon, N. Y., Choi, J. S. (2008) Re-evaluation of the antioxidant prenylated flavonoids from the roots of Sophora flavescens. Biol. Pharm. Bull. 31: 908-915
20. Kador, P. F., Kinoshita, J. H., Tung, W. H., Chylack, L. T. Jr. (1980) Differences in the susceptibility of various aldose reductases to inhibition. II. Invest. Ophthalmol. Vis. Sci. 19: 980-982
21. Kadota. S., Basnet, P., Hase, K., Namba, T. (1994) Matteuorienate A and B, two new and potent aldose reductase inhibitors from Matteuccia orientalis (Hook.) Trev. Chem. Pharm. Bull. 42: 1712-1714
22. Kaneko, M., Bucciarelli, M., Hwang, Y. C., Lee. L., Yan. S. F., Schmidt, A. M., Ramasamy, R. (2005) Aldose reductase and AGE-RAGE pathway: key players in myocardial ischemic injury. Ann. NY Acad. Sci. 1043: 702-709
23. Kang, T. H., Jeong, S. J., Ko, W. G., Kim, N. Y., Lee. B. H., Inagaki, M., Miyamoto. T., Higuchi, T., Kim, Y. C. (2000) Cytotoxic lavandulyl flavanones from Sophora flavescens. J. Nat. Prod. 63: 680-681
24. Kato, A., Higuchi, Y., Goto, H., Kizu, H., Okamoto, T., Asano, N., Hollinshead. J., Nash, R. J., Adachi, I. (2006) Inhibitory effects of Zingiber officinale Roscoe derived components on aldose reductase activity in vitro and in vivo. J. Agric. Food Chem. 54: 6640-6644
25. Kawanishi, K., Ueda. H., Moriyasu, M. (2003) Aldose reductase inhibitors from nature. Curr. Med. Chem. 10: 1353-1374
26. Kim, D. W., Chi. Y. S., Son, K. H., Chang, H. W., Kim, J. S., Kang, S. S., Kim, H. P. (2002) Effects of sophoraflavanone G, a prenylated flavonoid from Sophora flavescens, on cyclooxygenase-2 and in vivo inflammatory response. Arch. Pharm. Res. 25: 329-335
27. Kim, S. J., Son, K. H., Chang, H. W., Kang, S. S., Kim, H. P. (2003) Tyrosinase inhibitory prenylated flavonoids from Sophora flavescens. Biol. Pharm. Bull. 26: 1348-1350
28. Kim, J. H., Ryu, Y. B., Kang, N. S., Lee, B. W., Heo, J. S., Jeong, I. Y., Park, K. H. (2006) Glycosidase inhibitory flavonoids from Sophora flavescens. Biol. Pharm. Bull. 29: 302-305
29. Ko, W. G., Kang, T. H., Kim, N. Y., Lee, S. J., Kim, Y. C., Ko, G. I., Ryu. S. Y., Lee, B. H. (2000) Lavandulylflavonoids: a new class of in vitro apoptogenic agents from Sophora flavescens. Toxicol. In Vitro 14: 429-433
30. Lim, S. S., Jung, S. H., Ji, J., Shin, K. H., Keum, S. R. (2001) Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues. J. Pharm. Pharmacol. 53: 653-668
31. Lim, S. S., Jung, Y. J., Hyun, S. K., Lee, Y. S., Choi, J. S. (2006) Rat lens aldose reductase inhibitory constituents of Nelumho nucifera stamens. Phytother. Res. 20: 825-830
32. Manzanaro, S., Salva, J., de la Fuente, J. (2006) A. Phenolic marine natural products as aldose reductase inhibitors. J. Nat. Prod. 69: 1485-1487
33. Matsuda, H., Morikawa, T., Toguchida, I., Yoshikawa, M. (2002) Structural requirements of flavonoids and related compounds for aldose reductase inhibitory activity. Chem. Pharm. Bull. 50: 788-795
34. Matsuda, H., Wang, T., Managi, H., Yoshikawa, M. (2003) Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg. Med. Chem. 11: 5317-5323
35. Nakagawa, T., Yokozawa, T., Terasawa. K., Shu, S., Juneja, L. R. (2002) Protective activity of green tea against free radical- and glucose-mediated protein damage. J. Agric. Food Chem. 50: 2418-2422
36. Nishimura, C., Yamaoka. T., Mizutani, M., Yamashita. K., Akera, T., Tanimoto, T. (1991) Purification and characterization of the recombinant human aldose reductase expressed in baculovirus system. Biochim. Biophys. Acta 1078: 171-178
37. Peyrou, J., Sternberg, M. (2006) Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes. Pathol. Biol. 54: 405-419
38. Piao, X L., Piao, X. S., Kim, S. W., Park, J. H., Kim, H. Y., Cai, S. Q. (2006) Identification and characterization of antioxidants from Sophora flavescens. Biol. Pharm. Bull. 29: 1911-1915
39. Rastelli. G., Antolini. L., Benvenuti, S., Costantino. L. (2000) Structural bases for the inhibition of aldose reductase by phenolic compounds. Bioorg. Med. Chem. 8: 1151-1158
40. Ryu, S. Y., Lee, H. S., Kim, Y. K., Kim, S. H. (1997) Determination of isoprenyl and lavandulyl positions of flavonoids from Sophora flavescens by NMR experiment. Arch. Pharm. Res. 20: 491-495
41. +-glucose cotransporter (SGLT) inhibitory flavonoids from the roots of Sophora flavescens. Bioorg. Med. Chem. 15: 3445-3449
42. Son, J. K., Park, J. S., Kim, J. A., Kim, Y., Chung, S. R., Lee. S. H. (2003) Prenylated flavonoids from the roots of Sophora flavescens with tyrosinase inhibitory activity. Planta Med. 69: 559-561
43. Tang, W., Eisenbrand, G. (1992) Chinese drugs of plant origin: chemistry, pharmacology, and use in traditional and modern medicine. Springer-Verlag, Berlin: Germany, pp 931-943
44. Thornalley, P. J. (2003) Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch. Biochem. Biophys. 419: 31-40
45. Vinson, J. A., Howard III, T. B. (1996) Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J. Nutr. Biochem. 7: 659-663
46. Wirasathien, L., Pengsuparp, T., Suttisri, R., Ueda, H., Moriyasu, M., Kawanishi. K. (2007) Inhibitors of aldose reductase and advanced glycation end-products formation from the leaves of Stelechocarpus cauliflorus R.E. Fr. Phytomedicine 14: 546-550
47. Wu, L., Miyase, T., Akira. U., Kuroyanagi. M., Noro, T. (1985) Studies on the constituents of Sophora flavescens. Chem. Pharm. Bull. 33: 3231-3236
48. Yoshikawa, M., Shimada, H., Nishida, N., Li, Y., Toguchida, I., Yamahara, J., Matsuda, H. (1998) Antidiabetic principles of natural medicines. II. Aldose reductase and alpha-glucosidase inhibitors from Brazilian natural medicine, the leaves of Myrcia multiflora DC. (Myrtaceae): structures of myrciacitrins I and II and myrciaphenones A and B. Chem. Pharm. Bull. 46: 113-119
49. Zhang, L., Xu. L., Xiao, S. S., Liao, Q. F., Li, Q., Liang, J., Chen, X. H., Bi, K. S. (2007) Characterization of flavonoids in the extract of Sophora flavescens Ait. by high-performance liquid chromatography coupled with diode-array detector and electrospray ionization mass spectrometry. J. Pharm. Biomed. Anal. 44: 1019-1028